Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
METAP1D - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MB21D2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PIGC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CEP350 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GPATCH4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BASP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PI4KB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PYURF - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
LOC101927137 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATF6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC25A44 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DCAF6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRRC2C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RAD23B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EXOC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PLK4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GAR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SETDB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ELK4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MSTO1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on